Literature DB >> 17680338

The effect of darifenacin on overactive bladders in female and male rabbits.

Robert M Levin1, Yung-Shun Juan, Catherine Whitback, Franciso C Perez-Martinez, Wei-Yu Lin.   

Abstract

Our current study utilized a model of bladder instability to compare the effectiveness of darifenacin, a selective m3 muscarinic antagonist, at inhibiting overactive bladder (OAB) dysfunction in both male and female rabbits. Twenty-four male and female NZ white rabbits were used for this experiment. Each rabbit was anesthetized and the carotid artery was cannulated for blood pressure (BP) monitoring and the left femoral artery was cannulated for acetylcholine (Ach) administration. The bladder dome was catheterized for monitoring bladder pressure and for cystometry. A ligature was placed around the urethra just distal to the bladder to induce OAB. After OAB developed, the response to four IV doses of darifenacin (0.003; 0.01; 0.03; 0.09 mg/kg) evaluated for their effects. Darifenacin: (1) was an equally potent inhibitor of the contractile response of both sexes to intra-arterial Ach, (2) had no effects on BP, (3) was a potent inhibitor of the frequency of OAB, but had a significantly less potent effect on the amplitude, and (4) Darifenacin showed a greater potency in the female rabbits than in the males. These studies provide support for the use of darifenacin in the treatment of OAB.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17680338     DOI: 10.1007/s11255-007-9251-5

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  22 in total

Review 1.  Urge incontinence and detrusor instability.

Authors:  C F Jabs; S L Stanton
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2001

2.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

3.  Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing.

Authors:  Kylie J Mansfield; Lu Liu; Frederick J Mitchelson; Kate H Moore; Richard J Millard; Elizabeth Burcher
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

4.  Comparison of darifenacin and oxybutynin in patients with overactive bladder: assessment of ambulatory urodynamics and impact on salivary flow.

Authors:  C R Chapple; P Abrams
Journal:  Eur Urol       Date:  2005-07       Impact factor: 20.096

Review 5.  Darifenacin in the treatment of overactive bladder.

Authors:  Francois Haab
Journal:  Drugs Today (Barc)       Date:  2005-07       Impact factor: 2.245

6.  Oestrogen-induced changes in muscarinic receptor density and contractile responses in the female rabbit urinary bladder.

Authors:  S Batra; K E Andersson
Journal:  Acta Physiol Scand       Date:  1989-09

Review 7.  Muscarinic antagonists in development for disorders of smooth muscle function.

Authors:  R M Wallis; C M Napier
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

8.  Pressure-flow variables in patients treated with tolterodine for detrusor overactivity.

Authors:  A Wagg; J Malone-Lee
Journal:  BJU Int       Date:  2003-12       Impact factor: 5.588

9.  Autonomic innervation of rabbit urinary bladder following estrogen administration.

Authors:  R M Levin; D Jacobowitz; A J Wein
Journal:  Urology       Date:  1981-05       Impact factor: 2.649

Review 10.  Antimuscarinics and the overactive detrusor--which is the main mechanism of action?

Authors:  K-E Andersson; M Yoshida
Journal:  Eur Urol       Date:  2003-01       Impact factor: 20.096

View more
  2 in total

1.  Darifenacin hydro-bromide.

Authors:  S Selvanayagam; B Sridhar; K Ravikumar
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-05-14

Review 2.  Sex differences in the physiology and pharmacology of the lower urinary tract.

Authors:  Phani B Patra; Sayani Patra
Journal:  Curr Urol       Date:  2013-02-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.